1. Adams H, Avendaño J, Raza SM, et al. Prognostic factors and survival in primary malignant astrocytomas of the spinal cord: a population-based analysis from 1973 to 2007. Spine (Phila Pa 1976) 2012;37(12):E727-35.
3. Miller DC. Surgical pathology of intramedullary spinal cord neoplasms. J Neurooncol 2000;47:189-94.
7. Kim MS, Chung CK, Choe G, et al. Intramedullary spinal cord astrocytoma in adults: postoperative outcome. J Neurooncol 2001;52:85-94.
8. O’Sullivan C, Jenkin RD, Doherty MA, et al. Spinal cord tumors in children: long-term results of combined surgical and radiation treatment. J Neurosurg 1994;81:507-12.
9. Rodrigues GB, Waldron JN, Wong CS, et al. A retrospective analysis of 52 cases of spinal cord glioma managed with radiation therapy. Int J Radiat Oncol Biol Phys 2000;48:837-42.
10. Shirato H, Kamada T, Hida K, et al. The role of radiotherapy in the management of spinal cord glioma. Int J Radiat Oncol Biol Phys 1995;33:323-8.
12. Diaz-Aguilar D, ReFaey K, Clifton W, et al. Prognostic factors and survival in low grade gliomas of the spinal cord: a population-based analysis from 2006 to 2012. J Clin Neurosci 2019;61:14-21.
13. Hamilton KR, Lee SS, Urquhart JC, et al. A systematic review of outcome in intramedullary ependymoma and astrocytoma. J Clin Neurosci 2019;63:168-75.
14. Abdel-Wahab M, Etuk B, Palermo J, et al. Spinal cord gliomas: a multi-institutional retrospective analysis. Int J Radiat Oncol Biol Phys 2006;64:1060-71.
15. Linstadt DE, Wara WM, Leibel SA, et al. Postoperative radiotherapy of primary spinal cord tumors. Int J Radiat Oncol Biol Phys 1989;16:1397-403.
16. Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991;21:109-22.
19. Partridge AH, Hughes ME, Warner ET, et al. Subtype-dependent relationship between young age at diagnosis and breast cancer survival. J Clin Oncol 2016;34:3308-14.
21. Dubbink HJ, Atmodimedjo PN, Kros JM, et al. Molecular classification of anaplastic oligodendroglioma using nextgeneration sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial. Neuro Oncol 2016;18:388-400.
22. Murphy ES, Leyrer CM, Parsons M, et al. Risk factors for malignant transformation of low-grade glioma. Int J Radiat Oncol Biol Phys 2018;100:965-71.
25. McCormack BM, Miller DC, Budzilovich GN, et al. Treatment and survival of low-grade astrocytoma in adults--1977-1988. Neurosurgery 1992;31:636-42. discussion 642.